Unpublished conference/Abstract (Scientific congresses and symposiums)
New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and patients follow-up.
Schoumacher, Matthieu; LAMBERT, Vincent; Hansen, Sylvain et al.
201912èmes journées RFMF
 

Files


Full Text
abstract_RFMF19_final.docx
Publisher postprint (14.75 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Metabolomics; NMR; AMD
Abstract :
[en] Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly population in developed countries. 90% of all vision loss due to AMD result from the exudative form of this pathology, which is characterized by a choroidal neovascularization (CNV). Currently, diagnosis of AMD relies on ophthalmologic exams and treatments of the exudative form are based on the use of anti-angiogenic drug targeting vascular endothelial growth factors. Despite these advance, several clinical challenges have to be overcome. Among those, the identification of biomarkers that could allow to refine patient stratification, to follow disease progression and evaluate responses to treatment are mandatory. For this purpose, we decide to apply NMR-based metabolomics approach on both AMD patients and on a laser-induced murine choroidal neovascularization experimental model. In the clinical study, the metabolomics approach does not allow a complete differentiation between control and AMD patients. However, focusing only on AMD group, a clear-cut separation between active and non-active phases could be highlighted. In the mice model, discrimination between laser-induced and control mice occurs only when CNV is installed. In both human and animal studies, lactate and lipoprotein profile were identified as the main biomarkers. Mechanistically, we demonstrated that lactate, plays a critical role in the onset of the inflammatory and angiogenic phases and could be correlated with the CNV development. Then, controlling lactate level appears as a new therapeutic approach of AMD On the other hand, lipoprotein profile is of particular interest for patient follow-up. Indeed, evaluation of lipoprotein profile change trough a simple methods allowed us to establish clear modification of profiles according to the active or non-active status of the patient and to the induced or non-induced status of the mice. This work focuses on the lipoprotein profile and on the development of a methodology that could be used to characterize and compared the different profiles in the human and the mice studies.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Schoumacher, Matthieu ;  Université de Liège - ULiège > Cancer-Tumours and development biology
LAMBERT, Vincent  ;  Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service d'ophtalmologie
Hansen, Sylvain
Leenders, Justine
Govaerts, Bernadette
Rakic, Jean-Marie ;  Université de Liège - ULiège > Département des sciences cliniques > Ophtalmologie
Noël, Agnès ;  Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
De Tullio, Pascal ;  Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Language :
English
Title :
New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and patients follow-up.
Publication date :
23 May 2019
Event name :
12èmes journées RFMF
Event organizer :
Réseau Francophone de Métabolomique et Fluxomique
Event place :
Clermont-Ferrand, France
Event date :
21 au 23 mai 2019
Audience :
International
Available on ORBi :
since 13 May 2020

Statistics


Number of views
51 (3 by ULiège)
Number of downloads
1 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi